Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Conti

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|July 12, 2023
Reduced Graphene Oxide Electrolyte-Gated Transistor Immunosensor with Highly Selective Multiparametric Detection of Anti-Drug AntibodiesMatteo Sensi, Rafael Furlan de Oliveira, Marcello Berto, et al.
International Journal of Dermatology|January 5, 2024
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohortRiccardo Viola, Luca Mastorino, Matteo Megna, et al.
The Journal of Dermatological Treatment|September 27, 2019
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world studyAndrea Chiricozzi, Anna Balato, Curdin Conrad, et al.
Acta Dermato-Venereologica|December 3, 2020
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME StudyMarina Talamonti, Giovanna Malara, Ylenia Natalini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 15, 2025
Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal SarcomaAndrea Baudo, Mario de Angelis, Carolin Siech, et al.
Clinical, Cosmetic and Investigational Dermatology|January 13, 2023
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME StudyLuca Stingeni, Giovanna Malara, Andrea Conti, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 20, 2018
Long-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patientsMihai D Vartolomei, Deliu V Matei, Giuseppe Renne, et al.
Dermatology Practical & Conceptual|November 14, 2025
GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift ProgramsGiulio Gualdi, Laura Bigi, Clara De Simone, et al.
Dermatology and Therapy|June 5, 2026
Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate PsoriasisLuigi Gargiulo, Antonio Costanzo, Piergiorgio Malagoli, et al.
European Journal of Dermatology : EJD|March 2, 2021
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasisAndrea Chiricozzi, Antonio Costanzo, Maria Concetta Fargnoli, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Advanced Materials (Deerfield Beach, Fla.)|July 12, 2023
Reduced Graphene Oxide Electrolyte-Gated Transistor Immunosensor with Highly Selective Multiparametric Detection of Anti-Drug AntibodiesMatteo Sensi, Rafael Furlan de Oliveira, Marcello Berto, et al.
International Journal of Dermatology|January 5, 2024
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohortRiccardo Viola, Luca Mastorino, Matteo Megna, et al.
The Journal of Dermatological Treatment|September 27, 2019
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world studyAndrea Chiricozzi, Anna Balato, Curdin Conrad, et al.
Acta Dermato-Venereologica|December 3, 2020
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME StudyMarina Talamonti, Giovanna Malara, Ylenia Natalini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 15, 2025
Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal SarcomaAndrea Baudo, Mario de Angelis, Carolin Siech, et al.
Clinical, Cosmetic and Investigational Dermatology|January 13, 2023
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME StudyLuca Stingeni, Giovanna Malara, Andrea Conti, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 20, 2018
Long-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patientsMihai D Vartolomei, Deliu V Matei, Giuseppe Renne, et al.
Dermatology Practical & Conceptual|November 14, 2025
GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift ProgramsGiulio Gualdi, Laura Bigi, Clara De Simone, et al.
Dermatology and Therapy|June 5, 2026
Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate PsoriasisLuigi Gargiulo, Antonio Costanzo, Piergiorgio Malagoli, et al.
European Journal of Dermatology : EJD|March 2, 2021
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasisAndrea Chiricozzi, Antonio Costanzo, Maria Concetta Fargnoli, et al.
Pageof 17